Intermittent and episode-driven use of pranlukast to reduce the frequency of wheezing in atopic children: a randomized, double-blind, placebo-controlled trial

BACKGROUND: Leukotriene receptor antagonist (LTRA) therapy reduces asthma exacerbations in children older than 2 years. However, whether early intervention using LTRA in atopic smaller children aged 1 to 2 years who had experienced episodic wheezing can reduce the frequency of wheezing is unknown. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Ebisawa, Motohiro, Terada, Akihiko, Sato, Kazuki, Kurosaka, Fumitake, Kondo, Naomi, Sugizaki, Chizuko, Morikawa, Akihiro, Nishima, Sankei, Urashima, Mitsuyoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4382836/
https://www.ncbi.nlm.nih.gov/pubmed/25866598
http://dx.doi.org/10.1186/s40413-015-0062-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4382836/
https://www.ncbi.nlm.nih.gov/pubmed/25866598
http://dx.doi.org/10.1186/s40413-015-0062-3

Ejemplares similares